RD
Richard R. DeLuca
EVP&Pres, Merck Animal Heallth

Richard R. DeLuca insider trades: Merck (MRK) stock sales

EVP&Pres, Merck Animal Heallth, Merck Last trade Aug 12, 2026 50 Form 4 filings
$11.3M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2018
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Richard reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 12, 2026MRK↓ Sell$5.9M
Aug 6, 2026MRK↓ Sell$789K
Feb 6, 2026MRK↓ Sell$4.6M
Nov 8, 2023MRK↓ Sell$4.6M
May 1, 2023MRK↓ Sell$16.4M
Oct 28, 2022MRK↓ Sell$16.5M
Nov 4, 2021MRK↓ Sell$2.7M
Oct 29, 2021MRK↓ Sell$11.9M
Aug 9, 2019MRK↓ Sell$3.2M
May 3, 2019MRK↓ Sell$2.8M
Oct 30, 2018MRK↓ Sell$1.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MRK insiders

Open-market trades in the last 12 months

About Richard R. DeLuca's insider trades

Richard R. DeLuca is EVP&Pres, Merck Animal Heallth at Merck (MRK). Since Oct 30, 2018, Richard has reported no open-market purchases and 11 sales worth $71.2M on SEC Form 4. In the last 12 months: 3 sales ($11.3M).

Their filings also include grants and awards (34 filings), option exercises (11 filings), shares withheld for taxes (8 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.